HighVista Strategies »

NCR Atleos Corp shares owned by HighVista Strategies

Quarter-by-quarter ownership of NCR Atleos Corp (NATL) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in NCR Atleos Corp

Tip: Access up to 7 years of quarterly data

All positions including NCR Atleos Corp held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in NCR Atleos Corp by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.7M 40k 43.58
2025-03-31 $1.6M 62k 26.38

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Spyre Therapeutics Com New (SYRE)
Vaxcyte (PCVX)
Revolution Medicines (RVMD)
Terns Pharmaceuticals (TERN)
Structure Therapeutics Sponsored Ads (GPCR)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Soleno Therapeutics (SLNO)
Tyra Biosciences (TYRA)
Amylyx Pharmaceuticals (AMLX)
Amazon (AMZN)

View all positions for HighVista Strategies

Top funds holding NCR Atleos Corp

BlackRock
Vanguard Group
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Engine Capital Management
Hanna Zanoni
Fourth Sail Capital
Bank of America Corporation
Geode Capital Management
Dimensional Fund Advisors
Victory Capital Management
Alta Fox Capital Management
Coliseum Capital Management
Charles Schwab Investment Management

View all funds holding NCR Atleos Corp